Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation

Obstetrics and Gynecology

Volumn 87, Issue 5, 1996, Pages 683-691

  Silver, Richard K ^a,b   Vyskocil, Christine ^a,b   Solomon, Shari L ^a,b   Ragin, Ann ^a,b   Neerhof, Mark G ^a,b   Farrell, Elaine E ^a,b  

^a EVANSTON HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; SURFACTANT;

ADULT; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; PNEUMOTHORAX; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0029912536     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00033-6     Document Type: Article

References (31)

1. Collaborative Group on Antenatal Steroid Therapy. Effects of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981;141:276-87.
2. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990;97:11-25.
3. Gamsu HR, Mullinger BM, Donnai P, Dash CH. Antenatal administration of betamethasone to prevent respiratory distress syndrome in premature infants: Report of a UK multicentre trial. Br J Obstet Gynaecol 1989;96:409-10.
4. National Institutes of Health. NIH Consensus Development Conference on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8.
5. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics 1985;76:145-53.
6. Kwong MS, Egan EA, Notter RH, Shapiro DL. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 1985;76:585-92.
7. Merritt TA, Hallman M, Bloom BT, Berry C, Benirschke K, Sahn D, et al. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 1986;315:785-90.
8. Kendig JW, Notter RH, Cox C, Aschner JL, Benn S, Bernstein RM, et al. Surfactant replacement therapy at birth: Final analysis of a clinical trial and comparisons with similar trials. Pediatrics 1988; 82:756-62.
9. Soil RF, Hoekstra RE, Fangman JJ, Corbet AJ, Adams JM, James LS, et al. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics 1990;85:1092-102.
10. Bose C, Corbet A, Bose G, Garcia-Prats J, Lombardy L, Wold D, et al. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant. J Pediatr 1990;117:947-53.
11. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trial. J Pediatr 1991;118:277-84.
12. Stevenson D, Walther F, Long W, Sell M, Pauly T, Gong A, et al. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. J Pediatr 1992;120: S3-12.
13. Farrell EE, Silver RK, Kimberlin LV, Wolf ES, Dusik JM. Impact of antenatal dexamethasone administration of respiratory distress syndrome in surfactant-treated infants. Am J Obstet Gynecol 1989;161:628-33.
14. Egan EA, Kwong M. Clinical results of multicenter open trial of Infasurf. Washington, DC: Ross Laboratory Special Conference, 1988.
15. Jobe AH, Mitchell BR, Gunkel JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993;168:508-13.
16. Elkady T, Jobe A. Corticosteroids and surfactant increase lung volumes and decrease rupture pressures of preterm rabbit lungs. J Appl Physiol 1987;63:1616-21.
17. Seidner S, Pettenazzo A, Ikegami M, Jobe A. Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol 1988;64:2366-71.
18. Ikegami M, Jobe AH, Seidner S, Yamada T. Gestational effects of corticosteroids and surfactant in ventilated rabbits. Pediatr Res 1989;25:32-7.
19. Ikegami M, Jobe AH, Pettenazzo A, Seidner SR, Berry DB, Ruffini L. Effects of maternal treatment with corticosteroids, T3, TRH, and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. Am Rev Respir Dis 1987;136:892-8.
20. Papile LA, Burstein J, Burnstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
21. Garite TJ, Rumney PJ, Briggs GG, Harding JA, Nageotte MP, Towers CV, et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992;166:646-51.
22. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo-controlled multicenter study. Pediatrics 1994;93:730-6.
23. Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 1991;324:865-71.
24. Kattwinkel J, Bloom BT, Delmore P, Davis CL, Farrell E, Friss H, et 690 Silver et al Dexamethasone and Surfactant al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 1993;92:90-8.
25. Silver RK, MacGregor SN, Farrell EE, Sholl JS, Hobart ED. Antenatal steroid therapy before 33 weeks' gestation. Int J Gynaecol Obstet 1993;41:23-6.
26. Ohlsson A. Treatments of preterm premature rupture of the membranes: A meta-analysis. Am J Obstet Gynecol 1989;160: 890-6.
27. American College of Obstetricians and Gynecologists. Committee on Maternal-Fetal Medicine. Antenatal corticosteroid therapy for fetal maturation. ACOG committee opinion no. 147. Washington DC: American College of Obstetricians and Gynecologists, 1994.
28. Bunkett G, Bauer CR, Morrison JC. Effect of prenatal dexametha-sone administration on prevention of RDS in twin pregnancies. J Perinatol 1986;6:304-8.
29. Ardila J, Le Guennec J, Papageorgiou A. Influence of antenatal betamethasone and gender cohabitation on outcome of twin pregnancies 24 to 34 weeks of gestation. Semin Perinatol 1994;18:15-8.
30. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 1994;330:1476-80.
31. Leviton A, Kuban KC, Pagano M, Alfred EN, Van Marter L. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics 1993;91:1083-8.